The Department of Veterans Affairs (VA) Veterans Integrated Service Network 17 (VISN 17) awarded Isorx Texas LTD, a radiopharmaceuticals company, a single-award Indefinite Delivery Contract (IDC) valued at $226,318 to manufacture and deliver radiopharmaceuticals to support nuclear medicine services at VA facilities within the VISN 17 region. This IDC has an ultimate completion date of August 11, 2025.
Under this IDC, Isorx Texas LTD has received two fixed-price delivery orders to date: a $93,256.52 order to deliver radiopharmaceuticals by November 9, 2023, and a $78,626.55 order for radiopharmaceuticals with a completion date of August 11, 2025. These delivery orders, as well as the overall IDC, were awarded without any set-aside designations. The contracted radiopharmaceutical products are intended to support diagnostic imaging capabilities for veterans receiving care at VISN 17 facilities, primarily located in Lubbock, Texas.
Generated 9/20/24, 9:06 AM